MML Investors Services
ANIP icon

MML Investors Services’s ANI Pharmaceuticals ANIP Stock Holding History

MML Investors Services’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,974
Closed -$551K – 2476
2024
Q1 		$551K Buy
+7,974
New +$481K ﹤0.01% 1740

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MML Investors Services's ANIP Position: Q2 2024 in Review

MML Investors Services sold out of ANI Pharmaceuticals (ANIP) in Q2 2024, closing a stake of 7,974 shares — an estimated $551K sold.

MML Investors Services first reported a position in ANIP in Q1 2024 and held it in 1 quarter. The position peaked at $551K in Q1 2024. 201 funds tracked by Wall St. Rank hold ANIP as of Q2 2024.

  • MML Investors Services reported no remaining ANI Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • MML Investors Services sold 7,974 ANI Pharmaceuticals shares in Q2 2024, an estimated $551K.
  • MML Investors Services first reported a position in ANI Pharmaceuticals in Q1 2024 and held it in 1 quarter.
  • MML Investors Services's ANI Pharmaceuticals position peaked at $551K in Q1 2024.
  • 201 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2024.

Based on MML Investors Services's 13F filing for Q2 2024, filed 14 Aug 2024.